BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ho JW, Poon RT, Sun CK, Xue WC, Fan ST. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver. World J Gastroenterol 2005; 11(2): 176-181 [PMID: 15633211 DOI: 10.3748/wjg.v11.i2.176]
URL: https://www.wjgnet.com/1007-9327/full/v11/i2/176.htm
Number Citing Articles
1
Amol Ramchandra Gadbail, Mugdha P. Mankar (Gadbail), Alka Hande, Minal S. Chaudhary, Shailesh M. Gondivkar, Sheetal Korde, Madhuri N. Gawande, Swati Patil, Satyjitraje Tekade, Aparna Sharma. Tumor angiogenesis: Role in locally aggressive biological behavior of ameloblastoma and keratocystic odontogenic tumorHead & Neck 2013; 35(3): 329 doi: 10.1002/hed.22960
2
Dimitrios Lytras, Vassileia Leontara, Maria Kefala, Periklis G. Foukas, Niki Giannakou, Abraham Pouliakis, Christos Dervenis, Ioannis G. Panayiotides, Petros Karakitsos. Microvessel Landscape Assessment in Pancreatic Ductal AdenocarcinomaPancreas 2015; 44(1): 87 doi: 10.1097/MPA.0000000000000197
3
Qi Zhang, Jiajun Wu, Xueli Bai, Tingbo Liang. Evaluation of Intra-Tumoral Vascularization in Hepatocellular CarcinomasFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.584250
4
Keigo Murakami, Atsuko Kasajima, Naoki Kawagishi, Satoshi Sekiguchi, Fumiyoshi Fujishima, Mika Watanabe, Yasufumi Sato, Noriaki Ohuchi, Hironobu Sasano. The prognostic significance of vasohibin 1–associated angiogenesis in patients with hepatocellular carcinomaHuman Pathology 2014; 45(3): 589 doi: 10.1016/j.humpath.2013.10.028
5
Alessia Virzì, Armando Andres Roca Suarez, Thomas F. Baumert, Joachim Lupberger. Oncogenic Signaling Induced by HCV InfectionViruses 2018; 10(10): 538 doi: 10.3390/v10100538
6
Toshitsugu Nakamura. Changes in Expression of Bile Canalicular CD10 and Sinusoidal CD105 (Endoglin) in Peritumoral Hepatic TissueTumori Journal 2009; 95(4): 495 doi: 10.1177/030089160909500415
7
Kuo-Shyang Jeng, I-Shyan Sheen, Shu-Sheng Lin, Chuen-Miin Leu, Chiung-Fang Chang. The Role of Endoglin in Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2021; 22(6): 3208 doi: 10.3390/ijms22063208
8
Vanderlei Segatelli, Ebe Christie de Oliveira, Ilka F. S. F. Boin, Elaine Cristina Ataide, Cecilia Amelia F. Escanhoela. Evaluation and comparison of microvessel density using the markers CD34 and CD105 in regenerative nodules, dysplastic nodules and hepatocellular carcinomaHepatology International 2014;  doi: 10.1007/s12072-014-9525-9
9
M. A. Abdelwa, M. M. Elbedew, A. M. Amin, A. K. Tawfik. Serum Endoglin and IL-6 Levels as Complementary Diagnostic Biomarkers for Hepatocellular Carcinoma in Egyptian Liver Cirrhosis PatientsResearch Journal of Immunology 2016; 10(1): 1 doi: 10.3923/rji.2017.1.7
10
Gabriel Corteze Netto, Cristina Birlem Bleil, Arlete Hilbig, Lígia Maria Barbosa Coutinho. Immunohistochemical evaluation of the microvascular density through the expression of TGF‐β (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomasNeuropathology 2008; 28(1): 17 doi: 10.1111/j.1440-1789.2007.00825.x
11
Smruti Mohanty, Donald Jensen. Hepatocellular Carcinoma2009; : 62 doi: 10.3109/9780203092880-6
12
Ana Campillo, Estela Solanas, Maria J. Morandeira, Tomas Castiella, Sara Lorente, Francisco Agustín Garcia-Gil, Elena Piazuelo, Alba de Martino, Maria T. Serrano. Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantationEuropean Journal of Gastroenterology & Hepatology 2014; 26(8): 871 doi: 10.1097/MEG.0000000000000131
13
A. I. Shchyogolev, E. A. Dubova, U. N. Tumanova. Vascularization of Hepatocellular Carcinoma Tissue Depends on Its Differentiation DegreeBulletin of Experimental Biology and Medicine 2012; 153(4): 490 doi: 10.1007/s10517-012-1749-x
14
Chang-Cheng Zhao, Wen-Wei Yu, Ying-Jie Qi, Liang-Fei Xu, Zi-Ran Wang, Ya-Wen Qiang, Fan Ma, Xiao-Ling Ma. Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cellsAnti-Cancer Drugs 2020; 31(3): 223 doi: 10.1097/CAD.0000000000000866
15
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrenceCritical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
16
Yamato Ninomiya, Soji Ozawa, Junya Oguma, Akihito Kazuno, Miho Nitta, Hiroshi Kajiwara, Yasufumi Sato. Expression of vasohibin‑1 and ‑2 predicts poor prognosis among patients with squamous cell carcinoma of the esophagusOncology Letters 2018;  doi: 10.3892/ol.2018.9249
17
Kenichirou Kato, Tadahiro Takada, Toshio Fukusato. Expression of vascular endothelial‐cadherin in human hepatocellular carcinoma tissuesHepatology Research 2007; 37(6): 444 doi: 10.1111/j.1872-034X.2007.00051.x
18
Decai Yu, Linyuan Zhuang, Xitai Sun, Jun Chen, Yongzhong Yao, Kui Meng, Yitao Ding. Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinomaBMC Cancer 2007; 7(1) doi: 10.1186/1471-2407-7-122
19
Ruixia Xie, Xiaoying Wang, Guoqing Qi, Zhiping Wu, Rong Wei, Peirong Li, Dekui Zhang. DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transitionTumor Biology 2016; 37(9): 12049 doi: 10.1007/s13277-016-5070-6
20
Hideyuki Yoshitomi, Souichi Kobayashi, Masayuki Ohtsuka, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Masaru Miyazaki. Specific Expression of Endoglin (CD105) in Endothelial Cells of Intratumoral Blood and Lymphatic Vessels in Pancreatic CancerPancreas 2008; 37(3): 275 doi: 10.1097/mpa.0b013e3181690b97
21
Young-Chan Kwon, Reina Sasaki, Keith Meyer, Ranjit Ray, J.-H. James Ou. Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver PathogenesisJournal of Virology 2017; 91(21) doi: 10.1128/JVI.01235-17
22
Aldona Kasprzak, Agnieszka Adamek. Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic TherapyInternational Journal of Molecular Sciences 2018; 19(12): 3887 doi: 10.3390/ijms19123887
23
Christopher D. Mann, Christopher P. Neal, Giuseppe Garcea, Margaret M. Manson, Ashley R. Dennison, David P. Berry. Prognostic molecular markers in hepatocellular carcinoma: A systematic reviewEuropean Journal of Cancer 2007; 43(6): 979 doi: 10.1016/j.ejca.2007.01.004
24
Noel Weidner. Angiogenesis: In Vivo Systems, Part AMethods in Enzymology 2008; 444: 305 doi: 10.1016/S0076-6879(08)02814-0
25
De-Cai Yu, Jun Chen, Yi-Tao Ding. Hypoxic and Highly Angiogenic Non-Tumor Tissues Surrounding Hepatocellular Carcinoma: The ‘Niche’ of Endothelial Progenitor CellsInternational Journal of Molecular Sciences 2010; 11(8): 2901 doi: 10.3390/ijms11082901
26
Madhu Shree Poddar, Yu-De Chu, Chau-Ting Yeh, Cheng-Hsien Liu. Deciphering hepatoma cell resistance to tyrosine kinase inhibitors: insights from a Liver-on-a-Chip model unveiling tumor endothelial cell mechanismsLab on a Chip 2024; 24(15): 3668 doi: 10.1039/D4LC00238E
27
Juliana Passos Paschoal, Vagner Bernardo, Nathalie Henriques Silva Canedo, Osmar Damasceno Ribeiro, Adriana Caroli-Bottino, Vera Lucia Pannain. Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpressionBMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-72
28
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_186-1
29
Ester Fonsatti, Michele Maio. Transforming Growth Factor-β in Cancer Therapy, Volume I2008; : 395 doi: 10.1007/978-1-59745-292-2_25
30
Zhen Fan Yang, Ronnie T.P. Poon. Vascular Changes in Hepatocellular CarcinomaThe Anatomical Record 2008; 291(6): 721 doi: 10.1002/ar.20668
31
Zhao-Shan Niu, Xiao-Jun Niu, Mei Wang. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalWorld Journal of Hepatology 2015; 7(1): 7-27 doi: 10.4254/wjh.v7.i1.7
32
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_6-1
33
Anna Benetti, Angiola Berenzi, Marco Gambarotti, Emirena Garrafa, Maurizio Gelati, Enrico Dessy, Nazario Portolani, Tullio Piardi, Stefano Maria Giulini, Arnaldo Caruso, Gloria Invernici, Eugenio Agostino Parati, Roberto Nicosia, Giulio Alessandri. Transforming Growth Factor-β1 and CD105 Promote the Migration of Hepatocellular Carcinoma–Derived EndotheliumCancer Research 2008; 68(20): 8626 doi: 10.1158/0008-5472.CAN-08-1218
34
Mateja Legan, Boštjan Luzar, Vera Ferlan Marolt. Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosisScandinavian Journal of Gastroenterology 2009; 44(9): 1101 doi: 10.1080/00365520903121685
35
Eray Yagmur, Mohamed Rizk, Sven Stanzel, Claus Hellerbrand, Frank Lammert, Christian Trautwein, Hermann E. Wasmuth, Axel M. Gressner. Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinomaEuropean Journal of Gastroenterology & Hepatology 2007; 19(9): 755 doi: 10.1097/MEG.0b013e3282202bea
36
Amit Nair, Nicola Ingram, Eldo T. Verghese, Imeshi Wijetunga, Alexander F. Markham, Judy Wyatt, K. Rajendra Prasad, P. Louise Coletta. CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinomaCellular Oncology 2020; 43(5): 835 doi: 10.1007/s13402-020-00530-8
37
Hiroaki Kobayashi, Takeo Kosaka, Shuji Mikami, Tokuhiro Kimura, Hiroshi Hongo, Michio Kosugi, Yasufumi Sato, Mototsugu Oya. Vasohibin-1 expression as a biomarker of aggressive nature in ductal adenocarcinoma of the prostate: a retrospective cohort study at two centres in JapanBMJ Open 2021; 11(11): e056439 doi: 10.1136/bmjopen-2021-056439
38
Keigo Murakami, Atsuko Kasajima, Naoki Kawagishi, Noriaki Ohuchi, Hironobu Sasano. Microvessel density in hepatocellular carcinoma: Prognostic significance and review of the previous published workHepatology Research 2015; 45(12): 1185 doi: 10.1111/hepr.12487
39
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 151 doi: 10.1007/978-3-319-26956-6_6
40
Osmar Damasceno Ribeiro, Nathalie Henriques Silva Canedo, Vera Lucia Pannain. Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological featuresClinics 2016; 71(11): 639 doi: 10.6061/clinics/2016(11)04
41
Zhao-You Tang, Lun-Xiu Qin, Hui-Chuan Sun, Qing-Hai Ye. Molecular Genetics of Liver Neoplasia2010; : 349 doi: 10.1007/978-1-4419-6082-5_19
42
Alka H. Hande, Amol R. Gadbail, Archana M. Sonone, Minal S. Chaudhary, Vijay Wadhwan, Atul Nikam. Comparative analysis of tumour angiogenesis in solid multicystic and unicystic ameloblastoma by using CD 105 (endoglin)Archives of Oral Biology 2011; 56(12): 1635 doi: 10.1016/j.archoralbio.2011.06.007
43
A. I. Shchyogolev, U. N. Tumanova, E. A. Dubova. Morphometric Evaluation of Vascularization of Hepatic Focal Nodular HyperplasiaBulletin of Experimental Biology and Medicine 2013; 156(2): 266 doi: 10.1007/s10517-013-2327-6
44
Hongyan Qian, Liping Yang, Wenjing Zhao, Haizhen Chen, Song He. A comparison of CD105 and CD31 expression in tumor vessels of hepatocellular carcinoma by tissue microarray and flow cytometryExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6553
45
Xing Gu, Xin Ji, Le-Hua Shi, Chang-Hong Yi, Yun-Peng Zhao, Ai-Hua Wang, Lun-Gen Lu, Wen-Bo Yu, Chun-Fang Gao. Transforming Growth Factor beta1 Gene Variation Leu10Pro Affects Secretion and Function in Hepatic CellsDigestive Diseases and Sciences 2012; 57(11): 2901 doi: 10.1007/s10620-012-2238-9
46
Yu-Quan Xiong, Hui-Chuan Sun, Wei Zhang, Xiao-Dong Zhu, Peng-Yuan Zhuang, Ju-Bo Zhang, Lu Wang, Wei-zhong Wu, Lun-Xiu Qin, Zhao-You Tang. Human Hepatocellular Carcinoma Tumor–derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial CellsClinical Cancer Research 2009; 15(15): 4838 doi: 10.1158/1078-0432.CCR-08-2780
47
Desong Xia, Xiyu Liu, Yuhan Liao, Huiling Wang, Yanmei Li, Jian He, Jing Zhang, Liping Zhong, Yuhuan Wang. Detection of Hepatoma Serum Marker CD105 with Hemin/Graphene/Aptamer NanoprobesJournal of Biomedical Nanotechnology 2024; 20(3): 457 doi: 10.1166/jbn.2024.3791
48
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 3443 doi: 10.1007/978-3-319-26956-6_186
49
Roberta Pang, Ronnie T.P. Poon. Angiogenesis and antiangiogenic therapy in hepatocellular carcinomaCancer Letters 2006; 242(2): 151 doi: 10.1016/j.canlet.2006.01.008
50
Jung Woo Eun, Chul Won Seo, Geum Ok Baek, Moon Gyeong Yoon, Hye Ri Ahn, Ju A. Son, Suna Sung, Do Wan Kim, Soon Sun Kim, Hyo Jung Cho, Jae Youn Cheong. Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular CarcinomaCancers 2020; 12(12): 3819 doi: 10.3390/cancers12123819
51
Wenjiao Zeng, Annette S. H. Gouw, Marius C. van den Heuvel, Grietje Molema, Sibrand Poppema, Eric J. van der Jagt, Koert P. de Jong. Hepatocellular Carcinomas in Cirrhotic and Noncirrhotic Human Livers Share Angiogenic CharacteristicsAnnals of Surgical Oncology 2010; 17(6): 1564 doi: 10.1245/s10434-009-0900-z
52
Lui Ng, Ronnie Tung Ping Poon, Roberta Pang. Biomarkers for predicting future metastasis of human gastrointestinal tumorsCellular and Molecular Life Sciences 2013; 70(19): 3631 doi: 10.1007/s00018-013-1266-8
53
Rehab A. Mohamed, Hend M. Maghraby, Eman M. Abd El Salam, Hala M. Nageb, Eman E. Ahmad, Nagwa A. Mohamed. Evaluation of serum endoglin as noninvasive marker in hepatocellular carcinomaThe Egyptian Journal of Internal Medicine 2015; 27(1): 15 doi: 10.4103/1110-7782.155832